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Abstract
BACKGROUND—Abnormal atrial repolarization is important in the development of atrial
fibrillation (AF), but no direct measurement is available in clinical medicine.
OBJECTIVE—To determine whether the QT interval, a marker of ventricular repolarization,
could be used to predict incident AF.
METHODS—We examined a prolonged QT corrected by the Framingham formula (QTFram) as a
predictor of incident AF in the Atherosclerosis Risk in Communities (ARIC) study. The
Cardiovascular Health Study (CHS) and Health, Aging, and Body Composition (Health ABC)
study were used for validation. Secondary predictors included QT duration as a continuous
variable, a short QT interval, and QT intervals corrected by other formulae.
RESULTS—Among 14,538 ARIC participants, a prolonged QTFram predicted a roughly two-fold
increased risk of AF (hazard ratio [HR] 2.05, 95% confidence interval [CI] 1.42–2.96, p<0.001).
No substantive attenuation was observed after adjustment for age, race, sex, study center, body
mass index, hypertension, diabetes, coronary disease, and heart failure. The findings were
validated in CHS and Health ABC and were similar across various QT correction methods. Also
in ARIC, each 10-ms increase in QTFram was associated with an increased unadjusted (HR 1.14,
95%CI 1.10–1.17, p<0.001) and adjusted (HR 1.11, 95%CI 1.07–1.14, p<0.001) risk of AF.
Findings regarding a short QT were inconsistent across cohorts.
CONCLUSIONS—A prolonged QT interval is associated with an increased risk of incident AF.
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INTRODUCTION
Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice.1 Major
population-based studies have focused on AF risk factors that are most closely related to
hemodynamic and atrial substrate abnormalities, such as hypertension, heart failure, and left
atrial enlargement. 1–4 However, computer modeling, animal models, and small human
studies make it clear that electrical abnormalities, particularly in atrial repolarization and
refractoriness, are also important in the pathogenesis of AF. 5–10
The QT interval obtained from the standard 12-lead ECG is a readily available, inexpensive,
and rapid measure of ventricular repolarization. However, it is not known if this
manifestation of ventricular repolarization can reflect clinically relevant atrial
electrophysiology. Both ventricular and atrial refractoriness are determined by several of the
same potassium and sodium currents, 11 suggesting that there is likely a within-person
correlation between the two. Of interest, small studies of individuals with the inherited Short
QT 12 and Long QT 13,14 Syndromes suggest an increased risk of AF among these rare
individuals with monogenically-mediated abnormalities in myocardial repolarization. A
recent analysis of the REGARDS (Reasons for Geographic and Racial Differences in
Stroke) study found that a longer corrected QT interval (QTc) is associated with stroke, but
the mechanism remains unknown. 15 A recent analysis of a large administrative database
demonstrated a J-shaped association between QTc and AF among patients referred for an
ECG. 16 We sought to determine if a longer QT interval might be an important predictor of
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incident AF in well characterized, population-based cohort studies free of selection bias for
ECG referral.
METHODS
We assessed the relationship between QT interval length and risk of incident AF in the
Atherosclerosis Risk in Communities (ARIC) cohort, a prospective population-based cohort
study. Because biological plausibility supports both longer or shorter atrial repolarization as
risk factors for AF (suggesting that a longer or shorter QT interval could be important), we
validated our findings in two independent prospective cohort studies, the Cardiovascular
Health Study (CHS) and the Health, Aging, and Body Composition (Health ABC) study.
Recruitment, characterization, and outcome ascertainment of ARIC, CHS, and Health ABC
have been described in detail previously. 18–20 ARIC was selected as the primary cohort
because it represents a relatively young and healthy population, limiting the roles of atrial
fibrosis and structural heart disease and therefore potentially optimally uncovering innate
electrophysiological abnormalities as the cause of AF. Each cohort’s research protocol was
approved by its respective institutional review board, and all participants provided written
informed consent. Brief descriptions of each are provided below:
ARIC
Between 1987–1989, 15,792 adults aged 45–64 years sampled from four US communities
(northwest suburbs of Minneapolis, MN; Washington County, MD; Jackson, MS; Forsyth
County, NC) underwent a comprehensive baseline assessment. Subsequent contact included
annual phone interviews and three repeat examinations spaced approximately three years
apart. 18 Standard resting 12-lead ECGs were performed at each visit. All measurements
were digitally recorded, and a globally-averaged QT interval was generated from the earliest
QRS onset and T-wave offset using all leads. All ECG waveforms were verified by visual
inspection. 21 Prevalent AF was identified from the baseline ECG, and incident AF was
identified from study visit ECGs, hospital discharge diagnoses, and death certificates. 22
Self-reported medication use in the 2 weeks prior to study entry was recorded. Methods of
ascertaining baseline hypertension (HTN), coronary heart disease (CHD), congestive heart
failure (CHF), and diabetes (DM) for each cohort are described in Supplementary Appendix
Table 1.
CHS
From 1989–1990, 5,201 adults aged 65 years and older were recruited from the Medicare
eligibility lists of four US counties (Forsyth, NC; Sacramento, CA; Washington, MD;
Alleghany, PA), and an additional 687 African-Americans were recruited from 1992–
1993. 19 Participants underwent a comprehensive baseline examination and were followed
by alternating semiannual phone calls and clinic visits until 1999 and phone calls every six
months thereafter. Resting 12-lead ECGs were recorded using MAC PC ECG Machines
(Marquette Electronics) and processed using the GE Marquette 12-SL program. 19 This
program measured the QT interval from a median QRS-T complex derived from all leads. 23
ECG waveforms were measured automatically after visual inspection for errors and quality.
Prevalent AF was identified from the baseline ECG, 24 and incident AF was identified by
study visit ECGs or hospital discharge diagnosis codes supplemented with Medicare
inpatient claims data. Participants were asked to provide containers of all medications used
in the 2 weeks prior to the baseline home interview. 25
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Between 1997–1998, 3,075 adults aged 70–79 years were sampled from two US regions
(Pittsburgh, PA; Memphis, TN). Participants underwent a comprehensive baseline exam and
were followed thereafter with semi-annual alternating phone calls and clinic visits. 20
Baseline ECGs were analyzed at the ECG core laboratory at Saint Louis University Medical
Center (St Louis, Missouri). ECGs were coded using the Minnesota Coding system and were
visually inspected for accuracy. 26 Analysts measured the QT interval from the start of the
QRS complex to the T-wave offset in three beats in lead II, and an average duration was
generated. Prevalent AF was identified from the baseline ECG or from Medicare claims
data. Incident AF was identified from the year 4 visit ECG, hospital discharge diagnoses, or
Medicare claims data provided through the National Center for Health Statistics’ Medicare
claims linkage. Participants provided medications used in the previous two weeks at the year
1 visit.
QT Interval Ascertainment
We excluded participants with known prevalent AF, QRS duration ≥120ms, left ventricular
hypertrophy (LVH), ventricular pre-excitation, Vaughan-Williams Class I or III
antiarrhythmic drug use, artificial pacing, or extremes of QT interval duration (>600 or <200
ms) at baseline. We corrected the QT interval using the Framingham, Fridericia, Hodge and
Bazett formulae (Supplementary Appendix Table 2). We used the Framingham formula for
primary analyses, a linear correction method that is recommended by American Heart
Association/American College of Cardiology/Heart Rhythm Society consensus and
previously used in population-based studies. 15,27 Our primary predictor was an abnormally
long Framingham-corrected QT interval (QTFram), defined as ≥460 ms in women and ≥450
ms in men. 27 Secondary predictors included abnormally long QT intervals corrected by the
other formulae, QTFram as a continuous variable, and abnormally short corrected QT
intervals (defined as ≤390 ms). 27 Incident AF was the primary outcome.
Statistical Analyses
Normally distributed continuous variables are presented as means ± SD, and variables that
were not normally distributed are presented as medians and interquartile ranges (IQR).
Hazard ratios (HR) and 95% confidence intervals (CI) for the association between QTc
interval and incident AF were obtained using Cox proportional hazards models. In CHS and
Health ABC, QTc as a continuous variable was not consistently amenable to analysis using
Cox proportional hazards models due to non-linear response, as assessed by restricted cubic
splines. Covariates in multivariable models included age, race, sex, body mass index (kg/
m2), study center, HTN, CHF, CHD, and DM. Race was analyzed as white versus non-
white. Sex and race-specific effects of our primary predictor (a prolonged QTFram) were
examined using stratified analyses and statistical tests for interaction. Missing values were
excluded from analyses. All analyses were performed using Stata Version 12 (College
Station, TX).
RESULTS
After the exclusion criteria were applied, our final study cohorts included 14,538
participants in ARIC, 4,745 in CHS, and 2,396 in Health ABC (Table 1).
Individuals with a prolonged QTFram had an increased risk of developing AF in all three
cohorts (Figure 1). The association persisted after multivariable adjustment for potential
confounders (Figure 2). Similar statistically significant findings also persisted in ARIC and
Health ABC regardless of the method of QT interval correction (Table 2). Although the
point estimates consistently demonstrated a positive association, statistical significance was
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not achieved in adjusted analysis using the Hodge correction in CHS. Stratified analyses
according to sex and race did not significantly change the association between a prolonged
QTc and risk of AF; there was no evidence for an interaction between either sex or race and
prolonged QTc.
Examining the corrected QT interval as a continuous variable in ARIC, every 10-ms
increase in QTFram was associated with an increased risk of AF, both prior to (HR 1.14,
95%CI 1.10–1.17, p<0.001) and after adjustment (HR 1.11, 95%CI 1.07–1.14, p<0.001).
Findings were consistent across correction methods used. Findings regarding a short QT
were inconsistent by method of QT interval correction and across cohorts (Table 3).
DISCUSSION
We found that individuals with a prolonged QTFram had an increased risk of AF. This
association was consistent across three prospective, population-based cohorts and remained
significant after adjustment for traditional AF risk factors. Our data also support a
continuous association between a longer QT and increased risk of AF. These findings
suggest that ventricular repolarization represents a new and easily identifiable marker of AF
risk that may provide insights into the pathophysiology of this arrhythmia.
Recent evidence has demonstrated an increased risk of AF in individuals with Long QT
Syndrome (LQTS). 13,14 While this rare syndrome is estimated to affect only 0.05% of the
general population, 28,29 the prevalence of a long QTc interval in our cohorts was
substantially higher at 1–9%. Therefore, it is unlikely our methods simply detected those
with an occult diagnosis of the LQTS—indeed, the larger prevalence observed suggests that
a phenomenon clinically relevant to the general population is present. A longer QT interval
may directly reflect a greater propensity to AF as a manifestation of aberrations in
refractoriness paralleled in the atrium and ventricle. For example, LQTS patients with
prolonged cardiomyocyte refractoriness exhibit polymorphic atrial tachycardia with an
undulating P-wave axis that has been termed “atrial torsades de pointes,” 30 a state known to
degenerate into AF. 31 An alternative explanation may be related to enhanced activity of the
late sodium current: increased late sodium entry into cardiomyocytes manifests on the 12-
lead ECG by prolonging the QT interval 32,33 and, by increasing intracellular calcium and
triggered automaticity, may promote AF. 34,35
Investigators in the REGARDS study demonstrated that individuals with a prolonged QT
had an increased risk of stroke independent of traditional risk factors, but no clear
explanation was provided. 15 Our finding that a prolonged QT increases the risk of AF
provides a potential explanation. Subsequent analyses to determine if AF mediates the
association between the QT interval and stroke may prove fruitful.
More recently, Nielson et al. provided an important analysis of nearly 300,000 patients from
the greater region of Copenhagen referred for an ECG. 16 Using covariates and incident
outcome data derived from Danish registries, they demonstrated a J-shaped association
between QTc (using both Framingham and Bazett corrections) and AF. These findings
compliment ours nicely, and our data address several limitations inherent to that study. First,
all participants in our three population-based cohort studies underwent 12 lead ECGs,
thereby avoiding any potential referral bias that may have been present in the Copenhagen
study. Second, because we were able to leverage the in-person data that was prospectively
collected as part of these cohort studies, we were able to adjust for important baseline
covariates such as body mass index and hypertension. Finally, our cohorts were enriched for
African Americans, extending these findings beyond a Northern European population. It is
unclear whether the relationship between a prolonged QTc and AF is genetic, due to an
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environmental exposure, or is a manifestation of AF-associated comorbidities. Because our
findings persisted after multivariable adjustment, we suspect this represents a process
independent of previously identified risk factors for AF, such as HTN and CHF. Future
examination of longitudinal cohorts that include younger individuals may be useful in
determining if a longer QTc present in childhood or young adulthood predicts long-term AF
risk. Additional future studies may also demonstrate whether AF patients with a longer QT
represent a clinically-distinct AF subtype that is more or less amenable to certain therapies.
For example, AF that arises due to a diffuse electrical abnormality may theoretically be less
responsive to ablation procedures or antiarrhythmic drugs that prolong refractoriness.
Of note, individuals with the inherited Short QT Syndrome may have increased rates of
AF, 12 a finding consistent with the notion that a shorter atrial effective refractory period
may facilitate reentry and the presumed multiple wavelets that may sustain AF. 5–10 We
observed inconsistent findings regarding a short corrected QT interval and incident AF.
These findings are clearly more complex and difficult to interpret than our consistent
observations regarding a long QT interval, but they may provide a source of valuable future
investigation to better understand differing mechanisms of AF between diverse populations.
Various methods to adjust the QT interval for heart rate exist. The Bazett formula is the
most frequently employed method in clinical practice, but it is inaccurate at faster and
slower rates. 27 Based on the AHA/ACCF/HRS consensus guidelines, we adjusted the QT
interval using the Framingham formula, a linear correction method in which the adjusted QT
is less dependent on heart rate. 27 This was also the primary correction formula in the
REGARDS study. It is important to note that our findings regarding a prolonged QT were
robust and consistent across correction methods.
Study Limitations
While medication use was rigorously obtained in each cohort, it remains possible that
participants on Class I or III antiarrhythmic drugs were incompletely ascertained. Similarly,
although AF diagnoses were identified from serial ECGs and hospitalizations, it is likely
that some AF was not detected. We thus cannot exclude the possibility that some under-
ascertained AF patients treated with undocumented antiarrhythmic drugs contributed to our
results—however, given our consistent findings across three different cohorts, we believe
this to be unlikely. Although measurement error in assessing the QT interval is possible, we
would not expect it to be differentially present in those who later did and did not develop
AF. Additionally, the 3 cohorts demonstrating consistent results represented two separate
ECG core labs. Finally, it is possible that individuals with a longer QT are more
aggressively monitored and therefore are more likely to have asymptomatic AF identified.
However, this would not appear to sufficiently explain our finding that a continuous
measure of QT predicted a progressively increased risk of AF.
Conclusions
We found that a longer QT interval is associated with an increased risk of incident AF. As a
readily available measurement on the routine 12-lead ECG, the QT interval may therefore
provide a widely applicable novel predictor of incident AF. Individuals with AF who have a
prolonged QT may also represent a distinct subtype of AF patients with abnormal
repolarization, and future investigation can determine if identification of this subtype is
useful in selecting particular therapeutic strategies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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QTc corrected QT interval
REGARDS Reasons for Geographic and Racial Differences in Stroke
ARIC Atherosclerosis Risk in Communities
CHS Cardiovascular Health Study
Health ABC Health, Aging, and Body Composition
HTN hypertension
CHD coronary heart disease
CHF congestive heart failure
DM diabetes mellitus
LVH left ventricular hypertrophy
QTFram QT corrected by Framingham formula
QTFrd QT corrected by Fridericia formula
QTB QT corrected by Bazett formula
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LQTS Long QT Syndrome
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Figure 1. Kaplan-Meier curves for incident atrial fibrillation in Atherosclerosis Risk in
Communities (ARIC) study, Cardiovascular Health Study (CHS), and Health, Aging, and Body
Composition (Health ABC) study participants with and without a prolonged corrected QT
interval
AF = atrial fibrillation. QTFram = QT interval corrected by Framingham formula.
Differences in proportions with and without AF are compared using log-rank tests.
Individuals with a prolonged QTFram had a significantly increased risk of AF in ARIC
(p<0.001), CHS (p<0.001) and Health ABC (p=0.02), compared to those without.
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Figure 2. Hazard ratios (HR) and 95% confidence intervals (CI) for risk of atrial fibrillation for
individuals with prolonged QT intervals corrected by the Framingham formula
Multivariable models are adjusted for age, race, sex, body mass index, study center,
hypertension, diabetes, coronary heart disease, and congestive heart failure. The vertical axis
represents a HR of 1. Error bars denote 95% confidence intervals.
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Health, Aging, and Body
Composition Study
(n=2,396)
Age, in years 54 ± 5.7 72 ± 5.5 74 ± 2.8
Female 8,115 (56%) 2,809 (59%) 1,274 (53%)
Body mass index, in kg/m2 28 ± 5.4 27 ± 4.8 27 ± 4.8
Race
 White 10,739 (74%) 4,996 (84%) 1,428 (60%)
 Black 3,754 (26%) 718 (15%) 968 (40%)
 Asian 32 (0.2%) 4 (0.1%) 0 (0%)
 American Indian/Alaskan Native 13 (0.1%) 9 (0.2%) 0 (0%)
 Other 0 (0%) 18 (0.4%) 0 (0%)
Hypertension 4,875 (34%) 2,682 (57%) 1,389 (58%)
Diabetes 1,660 (12%) 693 (15%) 345 (14%)
Coronary heart disease 607 (4.2%) 791 (17%) 466 (19%)
Congestive heart failure 626 (4.4%) 124 (2.6%) 64 (2.7%)
QT (uncorrected), in ms 399 ± 30 409 ± 34 412 ± 33
QTFram (Framingham), in ms 410 ± 16 416 ± 18 420 ± 21
QTFrd (Fridericia), in ms 410 ± 17 416 ± 19 421 ± 22
QTB (Bazett), in ms 416 ± 17 420 ± 19 426 ± 23
QTH (Hodge), in ms 410 ± 18 417 ± 21 421 ± 22
Long QTFram 174 (1.2%) 144 (3.0%) 118 (4.9%)
Short QTFram 996 (6.9%) 177 (3.7%) 91 (3.8%)
Follow-up, in years 19.7 (17.1–20.7) 14.0 (8.7–18.2) 7.0 (3.8–9.8)
Incident atrial fibrillation 1,470 (10%) 1,271 (27%) 562 (23%)
Values are reported as mean ± standard deviation, median (interquartile range), or number (percent).
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